Cargando…
Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4(+) T‐cells for the treatment of Hyper IgM1
Hyper IgM1 is an X‐linked combined immunodeficiency caused by CD40LG mutations, potentially treatable with CD4(+) T‐cell gene editing with Cas9 and a “one‐size‐fits‐most” corrective template. Contrary to established gene therapies, there is limited data on the genomic alterations following long‐rang...
Autores principales: | Canarutto, Daniele, Asperti, Claudia, Vavassori, Valentina, Porcellini, Simona, Rovelli, Elisabetta, Paulis, Marianna, Ferrari, Samuele, Varesi, Angelica, Fiumara, Martina, Jacob, Aurelien, Sergi Sergi, Lucia, Visigalli, Ilaria, Ferrua, Francesca, González‐Granado, Luis Ignacio, Lougaris, Vassilios, Finocchi, Andrea, Villa, Anna, Radrizzani, Marina, Naldini, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690452/ https://www.ncbi.nlm.nih.gov/pubmed/37916874 http://dx.doi.org/10.15252/embj.2023114188 |
Ejemplares similares
-
P1405: IN-DEPTH GENOME INTEGRITY EVALUATION AND GMP-COMPLIANT MANUFACTURING OF HDR GENE EDITED CD4+ T CELLS FOR THE TREATMENT OF HYPER IGM 1
por: Canarutto, Daniele, et al.
Publicado: (2023) -
Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo
por: Asperti, Claudia, et al.
Publicado: (2023) -
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome
por: Vavassori, Valentina, et al.
Publicado: (2021) -
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
por: Vavassori, Valentina, et al.
Publicado: (2023) -
P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS
por: Fiumara, Martina, et al.
Publicado: (2023)